Service Features
  • 275 words per page
  • Font: 12 point Courier New
  • Double line spacing
  • Free unlimited paper revisions
  • Free bibliography
  • Any citation style
  • No delivery charges
  • SMS alert on paper done
  • No plagiarism
  • Direct paper download
  • Original and creative work
  • Researched any subject
  • 24/7 customer support

It is sometimes difficult to be inspired when trying to write a persuasive essay, book report or thoughtful research paper. Often of times, it is hard to find words that best describe your ideas. VIPessays now provides a database of over 150,000 quotations and proverbs from the famous inventors, philosophers, sportsmen, artists, celebrities, business people, and authors that are aimed to enrich and strengthen your essay, term paper, book report, thesis or research paper.

Try our free search of constantly updated quotations and proverbs database.

QuotationsAuthorsTopicsKeywords
Browse Authors: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
(Click a letter to view the authors)
Letter "R" » Robert Hazlett Quotes
«in the most optimistic scenario.»
«We had heard some investors were expecting a much worse forecast for next year, and those fears have been allayed.»
«Pfizer is clearly a winner here. Pfizer is clearly putting their solid foot forward. They've got a good franchise and it's good potential for the next couple years.»
«It's not very confidence inspiring to pull your guidance, and because of that we're looking hard at our 2006 estimates.»
«We knew 2003 was going to be a challenge, but it appears it's going to be more of a challenge than we expected.»
«Even though there may be some good drugs available, it may take some time until they are more widely accepted,»
«For investors in Pfizer, this is a meaningful event. This risk has been a significant overhang for some time.»
«We believe that some [PAH] patients are already using the active ingredient for pulmonary arterial hypertension,»
«The big drug companies are under duress on almost every front. There are challenges everywhere from generics, from the FDA, from managed care and from self-appointed public watchdogs criticizing the industry, and with attacks on direct-to-consumer advertising,»
«It'll be a challenge for [Takeda] by themselves, ... Lilly has historically had a very good presence in the diabetes area. But [Takeda] has got a good drug.»

Research our database of over 800,000 top-quality pre-written papers plus 15,000 biographies for only $9.95/month.
Instant Account Activation. Register Now.